TMS for Treatment of Addiction and Its Psychiatric Comorbidities: Safety and Efficacy

Friday, April 24, 2026

1:30 PM - 2:45 PM PT

Location: America's Cup, Level 4

Presenter(s)

Hamed Ekhtiari, MD, PhD, DFISAM

Associate Professor and Division Chief
University of Texas Southwestern
Dallas, Texas

Slides Handouts
KB

Kathleen T. Brady, MD, PhD

Professor
Medical University of South Carolina
Chrlston, South Carolina
Manish K. Jha, MD

Associate Professor
UTSW
Dalaas, Texas

Slides
Victor Tang, MD

Assistant Professor
University of Toronto
Toronto, Ontario

This 75-minute Focus Session explores the expanding role of repetitive transcranial magnetic stimulation (rTMS) in treating substance use disorders and comorbid depression. Led by four leading experts, the session combines evidence-based presentations, real-world case discussions, and safety-focused guidance. Attendees will gain actionable strategies to implement rTMS protocols and optimize outcomes in complex dual-diagnosis populations.

Learning Objectives:

Learners will be able to:

Discuss patient selection, contraindications, and safety in using TMS in dual-diagnosis populations.
Examine evolving TMS stimulation protocols (e.g., intermittent theta burst, accelerated courses) and evidence from ongoing trials for people with SUD.
Explore clinical guidelines and decision-making frameworks for integrating rTMS into multidisciplinary addiction care.

Disclosure(s):

Hamed Ekhtiari, MD, PhD, DFISAM: No financial relationships to disclose

Kathleen T. Brady, MD, PhD: No financial relationships to disclose

Manish K. Jha, MD: Abbvie: Consultant/Advisory Board (Ongoing); Boehringer Ingelheim: Consultant/Advisory Board (Ongoing); IQVIA: Consultant/Advisory Board (Ongoing); Janssen: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Neurocrine: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Sanofi: Consultant/Advisory Board (Ongoing); Soterix: Honoraria for scholarly presentation (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Worldwide Clinical Trials: Consultant/Advisory Board (Ongoing)

Victor Tang, MD: No financial relationships to disclose